Literature DB >> 19712670

Intestinal cell-specific vitamin D receptor (VDR)-mediated transcriptional regulation of CYP3A4 gene.

Petr Pavek1, Katerina Pospechova, Lucie Svecova, Zdenka Syrova, Lucie Stejskalova, Jana Blazkova, Zdenek Dvorak, Jaroslav Blahos.   

Abstract

CYP3A4 is the most important drug-metabolizing enzyme that is involved in biotransformation of more than 50% of drugs. Pregnane X receptor (PXR) dominantly controls CYP3A4 inducibility in the liver, whereas vitamin D receptor (VDR) transactivates CYP3A4 in the intestine by secondary bile acids. Four major functional PXR-binding response elements of CYP3A4 have been discovered and their cooperation was found to be crucial for maximal up-regulation of the gene in hepatocytes. VDR and PXR recognize similar response element motifs and share DR3(XREM) and proximal ER6 (prER6) response elements of the CYP3A4 gene. In this work, we tested whether the recently discovered PXR response elements DR4(eNR3A4) in the XREM module and the distal ER6 element in the CLEM4 module (CLEM4-ER6) bind VDR/RXRalpha heterodimer, whether the elements are involved in the intestinal transactivation, and whether their cooperation with other elements is essential for maximal intestinal expression of CYP3A4. Employing a series of gene reporter plasmids with various combinations of response element mutations transiently transfected into four intestinal cell lines, electrophoretic mobility shift assay (EMSA) and chromatin immunoprecipitation assay (ChIP), we found that the CLEM4-ER6 motif interacts with VDR/RXRalpha heterodimer and partially cooperates with DR3(XREM) and prER6 in both basal and VDR-mediated inducible CYP3A4 regulation in intestinal cells. In contrast, eNR3A4 is involved only in the basal transactivation in intestinal cells and in the PXR-mediated rifampicin-induced transactivation of CYP3A4 in LS174T intestinal cells. We thus describe a specific ligand-induced VDR-mediated transactivation of the CYP3A4 gene in intestinal cells that differs from PXR-mediated CYP3A4 regulation in hepatocytes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19712670     DOI: 10.1016/j.bcp.2009.08.017

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  18 in total

1.  Camptothecin attenuates cytochrome P450 3A4 induction by blocking the activation of human pregnane X receptor.

Authors:  Yakun Chen; Yong Tang; Gregory T Robbins; Daotai Nie
Journal:  J Pharmacol Exp Ther       Date:  2010-05-26       Impact factor: 4.030

2.  CYP2R1 is a major, but not exclusive, contributor to 25-hydroxyvitamin D production in vivo.

Authors:  Jinge G Zhu; Justin T Ochalek; Martin Kaufmann; Glenville Jones; Hector F Deluca
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-09       Impact factor: 11.205

3.  Metformin suppresses pregnane X receptor (PXR)-regulated transactivation of CYP3A4 gene.

Authors:  Lucie Krausova; Lucie Stejskalova; Hongwei Wang; Radim Vrzal; Zdenek Dvorak; Sridhar Mani; Petr Pavek
Journal:  Biochem Pharmacol       Date:  2011-09-06       Impact factor: 5.858

4.  Intestinal CYP3A4 and midazolam disposition in vivo associate with VDR polymorphisms and show seasonal variation.

Authors:  Ranjit K Thirumaran; Jatinder K Lamba; Richard B Kim; Brad L Urquhart; Jamie C Gregor; Nilesh Chande; Yiping Fan; An Qi; Cheng Cheng; Kenneth E Thummel; Stephen D Hall; Erin G Schuetz
Journal:  Biochem Pharmacol       Date:  2012-03-30       Impact factor: 5.858

5.  Byakangelicin induces cytochrome P450 3A4 expression via transactivation of pregnane X receptors in human hepatocytes.

Authors:  Jian Yang; Xiaofei Luan; Haiyan Gui; Peng Yan; Dongfang Yang; Xiulong Song; Wei Liu; Gang Hu; Bingfang Yan
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

Review 6.  Nonviral gene transfer as a tool for studying transcription regulation of xenobiotic metabolizing enzymes.

Authors:  Barbara Bonamassa; Dexi Liu
Journal:  Adv Drug Deliv Rev       Date:  2010-08-14       Impact factor: 15.470

Review 7.  Interplay between vitamin D and the drug metabolizing enzyme CYP3A4.

Authors:  Zhican Wang; Erin G Schuetz; Yang Xu; Kenneth E Thummel
Journal:  J Steroid Biochem Mol Biol       Date:  2012-09-15       Impact factor: 4.292

8.  Ancestry-Adjusted Vitamin D Metabolite Concentrations in Association With Cytochrome P450 3A Polymorphisms.

Authors:  Robin Taylor Wilson; Loren D Masters; Jill S Barnholtz-Sloan; Anna C Salzberg; Terryl J Hartman
Journal:  Am J Epidemiol       Date:  2018-04-01       Impact factor: 4.897

9.  The evolution of farnesoid X, vitamin D, and pregnane X receptors: insights from the green-spotted pufferfish (Tetraodon nigriviridis) and other non-mammalian species.

Authors:  Matthew D Krasowski; Ni Ai; Lee R Hagey; Erin M Kollitz; Seth W Kullman; Erica J Reschly; Sean Ekins
Journal:  BMC Biochem       Date:  2011-02-03       Impact factor: 4.059

10.  Rifampicin Does not Significantly Affect the Expression of Small Heterodimer Partner in Primary Human Hepatocytes.

Authors:  Petr Pavek; Lucie Stejskalova; Lucie Krausova; Michal Bitman; Radim Vrzal; Zdenek Dvorak
Journal:  Front Pharmacol       Date:  2012-01-19       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.